open access publication

Article, 2023

Factor VIII genotype and the risk of developing high-responding or low-responding inhibitors in severe hemophilia A: data from the PedNet Hemophilia Cohort of 1,202 children

Haematologica, ISSN 1592-8721, 1476-5632, 1466-4860, 0390-6078, Volume 109, 4, Pages 1293-1296, 10.3324/haematol.2023.284095

Contributors

Andersson, Nadine Gretenkort (Corresponding author) [1] [2] Labarque, Veerle 0000-0002-5052-9274 [3] Kartal-Kaess, Mutlu 0000-0002-2713-3300 [4] [5] Pinto, Fernando [6] Mikkelsen, Torben Stamm [7] Ljung, Rolf Carl Ragnar 0000-0003-3999-8747 [2] Group, PedNet Study [8]

Affiliations

  1. [1] Lund University
    2. [NORA names: Sweden; Europe, EU; Nordic; OECD];
  2. [2] Skåne University Hospital
    3. [NORA names: Sweden; Europe, EU; Nordic; OECD];
  3. [3] Universitair Ziekenhuis Leuven
    4. [NORA names: Belgium; Europe, EU; OECD];
  4. [4] University Hospital of Bern
    5. [NORA names: Switzerland; Europe, Non-EU; OECD];
  5. [5] University of Bern
    6. [NORA names: Switzerland; Europe, Non-EU; OECD];

Keywords

PedNet, children, cohort, data, factor VIII genotype, factors, genotypes, hemophilia A, hemophilia cohort, high responders, inhibitors, low-responding inhibitors, risk, severe hemophilia A

Funders

  • Roche (Switzerland)
  • Novo Nordisk (Denmark)

Data Provider: Digital Science

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+